SHC PRODUCTS ARE SUBSTRATES OF ERBB-2 KINASE

被引:0
|
作者
SEGATTO, O
PELICCI, G
GIULI, S
DIGIESI, G
DIFIORE, PP
MCGLADE, J
PAWSON, T
PELICCI, PG
机构
[1] MT SINAI HOSP, SAMUEL LUNENFELD RES INST, DIV MOLEC & DEV BIOL, TORONTO M5G 1X5, ONTARIO, CANADA
[2] NCI, CELLULAR & MOLEC BIOL LAB, BETHESDA, MD 20892 USA
[3] UNIV PERUGIA, MONTELUCE POLICLIN, IST CLIN MED 1, I-06100 PERUGIA, ITALY
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The shc gene encodes three widely expressed proteins of 46, 52 and 66 kDa. Overexpression of p46shc and p52shc in NIH3T3 fibroblasts induces a tumorigenic phenotype. Shc products are phosphorylated on tyrosine by the activated epidermal growth factor receptor (EGFR) and become physically associated with EGFR via their SH2 domain. Thus Shc oncoproteins may play a role in mitogenic signal transduction. Here we report that Shc products are substrates also of the erbB-2 kinase and form complexes with the erbB-2 product in intact cells. In vitro, the bacterially expressed Shc SH2 domain is sufficient to reconstitute the high affinity Shc/erbB-2 interaction. The erbB-2 region required for Shc binding was narrowed down to the most COOH-terminal 179 residues of gp185erbB-2; within this region, phosphorylation of one or more of the erbB-2 autophosphorylation sites is required for Shc/gp185erbB-2 complex formation as well as optimal phosphorylation of Shc products by the erbB-2 kinase. Thus, Shc proteins may play a role in signal transduction by gp185erbB-2.
引用
收藏
页码:2105 / 2112
页数:8
相关论文
共 50 条
  • [41] Regulation of the ERBB-2 promoter by RBPJ kappa and NOTCH
    Chen, YY
    Fischer, WH
    Gill, GN
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (22) : 14110 - 14114
  • [42] ERBB-2 gene overexpression and amplification in uterine sarcomas
    Amant, F
    Vloeberghs, V
    Woestenborghs, H
    Debiec-Rychter, M
    Verbist, L
    Moerman, P
    Vergote, I
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 583 - 587
  • [43] HER-2/neu (erbB-2) and the cell cycle
    Busse, D
    Doughty, RS
    Arteaga, CL
    SEMINARS IN ONCOLOGY, 2000, 27 (06) : 3 - 8
  • [44] EXTRACELLULAR PORTIONS OF EGF RECEPTOR WITH TGFa AND ErbB-2
    Garrett, P. J.
    Lou, M. Z.
    McKern, N. M.
    Adams, T. E.
    Lovrecz, G. O.
    Jorissen, R. N.
    Nice, E. C.
    Burgess, A. W.
    Ward, C. W.
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2002, 58 : C5 - C5
  • [45] Erbb-2 kinase is required for constitutive STAT 3 activation in malignant human lung epithelial cells
    Fernandes, A
    Hamburger, AW
    Gerwin, BI
    INTERNATIONAL JOURNAL OF CANCER, 1999, 83 (04) : 564 - 570
  • [46] Dual kinase inhibition in the treatment of breast cancer: Initial experience with the EGFR/ErbB-2 inhibitor lapatinib
    Burris, HA
    ONCOLOGIST, 2004, 9 : 10 - 15
  • [47] erbB-2 (HER-2) and breast cancer progression
    Edgerton, SM
    Moore, D
    Merkel, D
    Thor, AD
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2003, 11 (03) : 214 - 221
  • [49] Heregulins and the ErbB-2/3/4 receptors in gliomas
    Manfred Westphal
    Leonie Meima
    Eva Szonyi
    Julie Lofgren
    Hildegard Meissner
    Wolfgang Hamel
    Karoly Nikolics
    and Mark X. Sliwkowski
    Journal of Neuro-Oncology, 1997, 35 : 335 - 346
  • [50] Clinicopathological significance of erbB-2 expression in colorectal carcinoma
    Chamberlain, NL
    Ward, RL
    Hawkins, NJ
    ONCOLOGY REPORTS, 1999, 6 (03) : 527 - 531